Synta completes direct public offering

Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Lexington, Mass. Business: Cancer, Autoimmune Date completed: 4/15/11 Type: Direct public offering Raised: $35.2 million Shares: 7.2 million Price: $4.89 Sha...